特别提示：包括重组人转录抑制蛋白1(DR1)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人转录抑制蛋白1(DR1)
英文名称：Recombinant Human Protein Down-Regulator of Transcription 1
产品货号：JN0879
产品规格：10μg|50μg|500μg|1mg

本品由我们的大肠杆菌表达系统制备而成，目的基因编码的Ala2-Ile176在C端含有His标签。

DR1质量控制：＞95%(还原性SDS-PAGE)

DR1制剂：冻干品

DR1保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

DR1复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于DR1：
Protein Dr1 (DR1) belongs to the NC2 beta/DR1 family. DR1 contains a histone fold motif at the amino terminus, a TBP-binding domain, and a glutamine- and alanine-rich region. DR1 as a TBP associated phosphoprotein that represses both basal and activated levles of transcription. DR1 is an component of the ADA2A-containing complex (ATAC) which posses histone acetyltransferase activity on histone H3 and H4.

根据您的关注的重组人转录抑制蛋白1(DR1)，重组人转录抑制蛋白1，重组人DR1，rhDR1，Recombinant Human Protein Down-Regulator of Transcription 1，重组转录抑制蛋白1，重组人Protein Down-Regulator of Transcription 1，rDR1，重组DR1，重组Protein Down-Regulator of Transcription 1，您可能还对以下产品有需求：
 

货号	名称	规格
JN0330	重组小鼠趋化因子CXCL15	10μg|50μg|500μg|1mg
JN0344	重组小鼠白介素IL-22(白细胞介素22)	10μg|50μg|500μg|1mg
JN1965	重组人泛素结合酶E2-K(UBCE2K)	10μg|50μg|500μg|1mg
JN0587	重组人Nectin-1(PVRL1)	10μg|50μg|500μg|1mg
JN0602	重组人嗜乳脂蛋白亚家族1成员A1(BTN1A1)	10μg|50μg|500μg|1mg
JN0644	重组人胶质瘤发病相关蛋白1(GLIPR1)	10μg|50μg|500μg|1mg

关注重组人转录抑制蛋白1(DR1)，重组人转录抑制蛋白1，重组人DR1，rhDR1，Recombinant Human Protein Down-Regulator of Transcription 1，重组转录抑制蛋白1，重组人Protein Down-Regulator of Transcription 1，rDR1，重组DR1，重组Protein Down-Regulator of Transcription 1的同时，为您推荐更多您可能感兴趣的产品：



名称：重组人Long-R3-IGF1
货号：JN0211
规格：10μg|50μg|500μg|1mg
本品由我们的大肠杆菌表达系统制备，目的基因编码的Gly49-Ala118表达纯化而来。

IGF1(Long-R3-IGF1)质量控制：＞95%(还原性SDS-PAGE)。

IGF1(Long-R3-IGF1)制剂：冻干品

IGF1(Long-R3-IGF1)保存：
冻干蛋白可在-20℃长期保存，室温也可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天。
复溶后建议分装冻存在-20℃，可保存3个月，应避免反复冻融。

IGF1(Long-R3-IGF1)复溶：
1、试剂开盖前请先离心。
2、复溶浓度应大于100 μg/ml.
3、冻干蛋白溶于ddH2O中
4、复溶后根据使用量分装保存，避免反复冻融。

关于IGF1(Long-R3-IGF1)：
Insulin-like growth factor I (IGF1) belongs to the family of insulin-like growth factors that are structurally homologous to proinsulin. Mature IGFs are generated by proteolytic processing of inactive precursor proteins, which contains the N- and C-terminal propeptide regions. Mature human IGF-I consisting of 70 amino acids has 94% identity with mouse IGF-I and exhibits cross-species activity. IGF-1 binds IGF-IR, IGF-IIR, and the insulin receptor and plays a key role in cell cycle progression, cell proliferation and tumor progression. IGF-1 expression is regulated by growth hormone. R3 IGF-1 is an 83 amino acid analog of IGF-1 comprising the complete human IGF-1 sequence with the substitution of an Arg (R) for the Glu(E) at position three, hence R3, and a 13 amino acid extension peptide at the N terminus. R3 IGF-1 has been produced with the purpose of increasing biological activity. R3 IGF-1 is significantly more potent than human IGF-I in vitro.